Quantitative ultrasound delta-radiomics during radiotherapy for monitoring treatment responses in head and neck malignancies

Aim: We investigated quantitative ultrasound (QUS) in patients with node-positive head and neck malignancies for monitoring responses to radical radiotherapy (RT). Materials & methods: QUS spectral and texture parameters were acquired from metastatic lymph nodes 24 h, 1 and 4 weeks after starting RT. K-nearest neighbor and naive-Bayes machine-learning classifiers were used to build prediction models for each time point. Response was detected after 3 months of RT, and patients were classified into complete and partial responders. Results: Single-feature naive-Bayes classification performed best with a prediction accuracy of 80, 86 and 85% at 24 h, week 1 and 4, respectively. Conclusion: QUS-radiomics can predict RT response at 3 months as early as 24 h with reasonable accuracy, which further improves into 1 week of treatment

Integrated Graph Theoretic, Radiomics, and Deep Learning Framework for Personalized Clinical Diagnosis, Prognosis, and Treatment Response Assessment of Body Tumors

Purpose: A new paradigm is beginning to emerge in radiology with the advent of increased computational capabilities and algorithms. The future of radiological reading rooms is heading towards a unique collaboration between computer scientists and radiologists. The goal of computational radiology is to probe the underlying tissue using advanced algorithms and imaging parameters and produce a personalized diagnosis that can be correlated to pathology. This thesis presents a complete computational radiology framework (I GRAD) for personalized clinical diagnosis, prognosis and treatment planning using an integration of graph theory, radiomics, and deep learning. Methods: There are three major components of the I GRAD framework–image segmentation, feature extraction, and clinical decision support. Image Segmentation: I developed the multiparametric deep learning (MPDL) tissue signature model for segmentation of normal and abnormal tissue from multiparametric (mp) radiological images. The segmentation MPDL network was constructed from stacked sparse autoencoders (SSAE) with five hidden layers. The MPDL network parameters were optimized using k-fold cross-validation. In addition, the MPDL segmentation network was tested on an independent dataset. Feature Extraction: I developed the radiomic feature mapping (RFM) and contribution scattergram (CSg) methods for characterization of spatial and inter-parametric relationships in multiparametric imaging datasets. The radiomic feature maps were created by filtering radiological images with first and second order statistical texture filters followed by the development of standardized features for radiological correlation to biology and clinical decision support. The contribution scattergram was constructed to visualize and understand the inter-parametric relationships of the breast MRI as a complex network. This multiparametric imaging complex network was modeled using manifold learning and evaluated using graph theoretic analysis. Feature Integration: The different clinical and radiological features extracted from multiparametric radiological images and clinical records were integrated using a hybrid multiview manifold learning technique termed the Informatics Radiomics Integration System (IRIS). IRIS uses hierarchical clustering in combination with manifold learning to visualize the high-dimensional patient space on a two-dimensional heatmap. The heatmap highlights the similarity and dissimilarity between different patients and variables. Results: All the algorithms and techniques presented in this dissertation were developed and validated using breast cancer as a model for diagnosis and prognosis using multiparametric breast magnetic resonance imaging (MRI). The deep learning MPDL method demonstrated excellent dice similarity of 0.87±0.05 and 0.84±0.07 for segmentation of lesions on malignant and benign breast patients, respectively. Furthermore, each of the methods, MPDL, RFM, and CSg demonstrated excellent results for breast cancer diagnosis with area under the receiver (AUC) operating characteristic (ROC) curve of 0.85, 0.91, and 0.87, respectively. Furthermore, IRIS classified patients with low risk of breast cancer recurrence from patients with medium and high risk with an AUC of 0.93 compared to OncotypeDX, a 21 gene assay for breast cancer recurrence. Conclusion: By integrating advanced computer science methods into the radiological setting, the I-GRAD framework presented in this thesis can be used to model radiological imaging data in combination with clinical and histopathological data and produce new tools for personalized diagnosis, prognosis or treatment planning by physicians

Investigation of intra-tumour heterogeneity to identify texture features to characterise and quantify neoplastic lesions on imaging

The aim of this work was to further our knowledge of using imaging data to discover image derived biomarkers and other information about the imaged tumour. Using scans obtained from multiple centres to discover and validate the models has advanced earlier research and provided a platform for further larger centre prospective studies. This work consists of two major studies which are describe separately: STUDY 1: NSCLC Purpose The aim of this multi-center study was to discover and validate radiomics classifiers as image-derived biomarkers for risk stratification of non-small-cell lung cancer (NSCLC). Patients and methods Pre-therapy PET scans from 358 Stage I–III NSCLC patients scheduled for radical radiotherapy/chemoradiotherapy acquired between October 2008 and December 2013 were included in this seven-institution study. Using a semiautomatic threshold method to segment the primary tumors, radiomics predictive classifiers were derived from a training set of 133 scans using TexLAB v2. Least absolute shrinkage and selection operator (LASSO) regression analysis allowed data dimension reduction and radiomics feature vector (FV) discovery. Multivariable analysis was performed to establish the relationship between FV, stage and overall survival (OS). Performance of the optimal FV was tested in an independent validation set of 204 patients, and a further independent set of 21 (TESTI) patients. Results Of 358 patients, 249 died within the follow-up period [median 22 (range 0–85) months]. From each primary tumor, 665 three-dimensional radiomics features from each of seven gray levels were extracted. The most predictive feature vector discovered (FVX) was independent of known prognostic factors, such as stage and tumor volume, and of interest to multi-center studies, invariant to the type of PET/CT manufacturer. Using the median cut-off, FVX predicted a 14-month survival difference in the validation cohort (N = 204, p = 0.00465; HR = 1.61, 95% CI 1.16–2.24). In the TESTI cohort, a smaller cohort that presented with unusually poor survival of stage I cancers, FVX correctly indicated a lack of survival difference (N = 21, p = 0.501). In contrast to the radiomics classifier, clinically routine PET variables including SUVmax, SUVmean and SUVpeak lacked any prognostic information. Conclusion PET-based radiomics classifiers derived from routine pre-treatment imaging possess intrinsic prognostic information for risk stratification of NSCLC patients to radiotherapy/chemo-radiotherapy. STUDY 2: Ovarian Cancer Purpose The 5-year survival of epithelial ovarian cancer is approximately 35-40%, prompting the need to develop additional methods such as biomarkers for personalised treatment. Patient and Methods 657 texture features were extracted from the CT scans of 364 untreated EOC patients. A 4-texture feature ‘Radiomic Prognostic Vector (RPV)’ was developed using machine learning methods on the training set. Results The RPV was able to identify the 5% of patients with the worst prognosis, significantly improving established prognostic methods and was further validated in two independent, multi-centre cohorts. In addition, the genetic, transcriptomic and proteomic analysis from two independent datasets demonstrated that stromal and DNA damage response pathways are activated in RPV-stratified tumours. Conclusion RPV could be used to guide personalised therapy of EOC. Overall, the two large datasets of different imaging modalities have increased our knowledge of texture analysis, improving the models currently available and provided us with more areas with which to implement these tools in the clinical setting.Open Acces

Comparison between A-mode and B-mode ultrasound in local hyperthermia monitoring

Hyperthermia therapy is one of the therapy methods used for cancer treatment. It has shown to be an effective way of treating the cancerous tissue when compared to surgery, chemotherapy and radiation. However, real time monitoring method is capable in delivering a consistent heat and preventing any damages to the nearby tissue. Ultrasound is among the widely used technique in clinical setting. A-Mode ultrasound involves one-dimensional (1D) signal processing which enables a quantitative measurement on different types of breast tissues to be conducted faster as it has relatively simple signal processing requirement. On the other hand, B-Mode ultrasound offers good spatial resolution for thermal monitoring. Therefore, the aim of this study is to investigate and to compare the most optimum A-Mode and B-Mode ultrasound parameters to monitor hyperthermia in normal and pathological breast tissue. A series of experiment was conducted on 40 female Sprague Dawley rats. The pathological and normal rats were dissected and exposed to hyperthermia at variation temperature of 37oC (body temperature) and 40oC, 45oC, 50oC and 55oC for hyperthermia temperatures. A-Mode and B-Mode of 7.5 Mhz and 6Mhz was used simultaneously during the experiment for collecting acoustic information and scanning purposes before and after the hyperthermia exposure. Result obtained shows that, for normal tissue condition of both A-Mode and B-Mode, the attenuation calculation to mean of pixel intensity found to be (3.59±0.04)dB and 187.68 at temperature value of 50 oC. Meanwhile, in pathological tissue condition, the attenuation value with respect to pixel intensity was obtained by (3.36±0.26)dB at temperature value of 45oC and 199.26 was achieved at temperature value of 40oC. For backscatter coefficient to variance analysis, the result found that, in both A-Mode and B-Mode normal tissue condition, at temperature value of 40oC, (1.81±0.25) of backscatter coefficient was obtained while at 45oC, the variance value of 3298.94 was achieved. In pathological tissue, the temperature value of 40oC and 55oC was the most pronounce temperature dependent of (1.45±0.28) for backscatter coefficient with respect to 3275.35 of variance analysis. The result obtained from artificial neural network have shown that, 91.67% to 87.5% of testing to validation percentage accuracy of A-Mode was achieved, while in B-Mode, 88.89% and 81.25% of testing and validation data was obtained. Therefore, it is shown that, the use of A-Mode with comparison to B-Mode ultrasound can be used as another potential approach since its attenuation to pixel intensity and backscatter coefficient with respect to variance of A-Mode and B-Mode is very sensitive to the tissue structure in monitoring hyperthermia therapy with respect to the changes of temperature

Texture Analysis Platform for Imaging Biomarker Research

abstract: The rate of progress in improving survival of patients with solid tumors is slow due to late stage diagnosis and poor tumor characterization processes that fail to effectively reflect the nature of tumor before treatment or the subsequent change in its dynamics because of treatment. Further advancement of targeted therapies relies on advancements in biomarker research. In the context of solid tumors, bio-specimen samples such as biopsies serve as the main source of biomarkers used in the treatment and monitoring of cancer, even though biopsy samples are susceptible to sampling error and more importantly, are local and offer a narrow temporal scope. Because of its established role in cancer care and its non-invasive nature imaging offers the potential to complement the findings of cancer biology. Over the past decade, a compelling body of literature has emerged suggesting a more pivotal role for imaging in the diagnosis, prognosis, and monitoring of diseases. These advances have facilitated the rise of an emerging practice known as Radiomics: the extraction and analysis of large numbers of quantitative features from medical images to improve disease characterization and prediction of outcome. It has been suggested that radiomics can contribute to biomarker discovery by detecting imaging traits that are complementary or interchangeable with other markers. This thesis seeks further advancement of imaging biomarker discovery. This research unfolds over two aims: I) developing a comprehensive methodological pipeline for converting diagnostic imaging data into mineable sources of information, and II) investigating the utility of imaging data in clinical diagnostic applications. Four validation studies were conducted using the radiomics pipeline developed in aim I. These studies had the following goals: (1 distinguishing between benign and malignant head and neck lesions (2) differentiating benign and malignant breast cancers, (3) predicting the status of Human Papillomavirus in head and neck cancers, and (4) predicting neuropsychological performances as they relate to Alzheimer’s disease progression. The long-term objective of this thesis is to improve patient outcome and survival by facilitating incorporation of routine care imaging data into decision making processes.Dissertation/ThesisDoctoral Dissertation Biomedical Informatics 201

Texture analysis and Its applications in biomedical imaging: a survey

Texture analysis describes a variety of image analysis techniques that quantify the variation in intensity and pattern. This paper provides an overview of several texture analysis approaches addressing the rationale supporting them, their advantages, drawbacks, and applications. This survey’s emphasis is in collecting and categorising over five decades of active research on texture analysis.Brief descriptions of different approaches are presented along with application examples. From a broad range of texture analysis applications, this survey’s final focus is on biomedical image analysis. An up-to-date list of biological tissues and organs in which disorders produce texture changes that may be used to spot disease onset and progression is provided. Finally, the role of texture analysis methods as biomarkers of disease is summarised.Manuscript received February 3, 2021; revised June 23, 2021; accepted September 21, 2021. Date of publication September 27, 2021; date of current version January 24, 2022. This work was supported in part by the Portuguese Foundation for Science and Technology (FCT) under Grants PTDC/EMD-EMD/28039/2017, UIDB/04950/2020, PestUID/NEU/04539/2019, and CENTRO-01-0145-FEDER-000016 and by FEDER-COMPETE under Grant POCI-01-0145-FEDER-028039. (Corresponding author: Rui Bernardes.)info:eu-repo/semantics/publishedVersio

The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology

With the rapid development of new technologies, including artificial intelligence and genome sequencing, radiogenomics has emerged as a state-of-the-art science in the field of individualized medicine. Radiogenomics combines a large volume of quantitative data extracted from medical images with individual genomic phenotypes and constructs a prediction model through deep learning to stratify patients, guide therapeutic strategies, and evaluate clinical outcomes. Recent studies of various types of tumors demonstrate the predictive value of radiogenomics. And some of the issues in the radiogenomic analysis and the solutions from prior works are presented. Although the workflow criteria and international agreed guidelines for statistical methods need to be confirmed, radiogenomics represents a repeatable and cost-effective approach for the detection of continuous changes and is a promising surrogate for invasive interventions. Therefore, radiogenomics could facilitate computer-aided diagnosis, treatment, and prediction of the prognosis in patients with tumors in the routine clinical setting. Here, we summarize the integrated process of radiogenomics and introduce the crucial strategies and statistical algorithms involved in current studies

Construction of machine learning-based models for cancer outcomes in low and lower-middle income countries: A scoping review

Background: The impact and utility of machine learning (ML)-based prediction tools for cancer outcomes including assistive diagnosis, risk stratification, and adjunctive decision-making have been largely described and realized in the high income and upper-middle-income countries. However, statistical projections have estimated higher cancer incidence and mortality risks in low and lower-middle-income countries (LLMICs). Therefore, this review aimed to evaluate the utilization, model construction methods, and degree of implementation of ML-based models for cancer outcomes in LLMICs. Methods: PubMed/Medline, Scopus, and Web of Science databases were searched and articles describing the use of ML-based models for cancer among local populations in LLMICs between 2002 and 2022 were included. A total of 140 articles from 22,516 citations that met the eligibility criteria were included in this study. Results: ML-based models from LLMICs were often based on traditional ML algorithms than deep or deep hybrid learning. We found that the construction of ML-based models was skewed to particular LLMICs such as India, Iran, Pakistan, and Egypt with a paucity of applications in sub-Saharan Africa. Moreover, models for breast, head and neck, and brain cancer outcomes were frequently explored. Many models were deemed suboptimal according to the Prediction model Risk of Bias Assessment tool (PROBAST) due to sample size constraints and technical flaws in ML modeling even though their performance accuracy ranged from 0.65 to 1.00. While the development and internal validation were described for all models included (n=137), only 4.4% (6/137) have been validated in independent cohorts and 0.7% (1/137) have been assessed for clinical impact and efficacy. Conclusion: Overall, the application of ML for modeling cancer outcomes in LLMICs is increasing. However, model development is largely unsatisfactory. We recommend model retraining using larger sample sizes, intensified external validation practices, and increased impact assessment studies using randomized controlled trial design